百度(09888.HK)彈8% 「文心一言」獲650企業加入生態圈
百度(09888.HK)今早高開反彈升近8%,現報135.5元,升8.3%。成交量352.8萬股,涉資4.76億。
百度昨日(16日)發布被視作是中國版ChatGPT的人工智能聊天機械人「文心一言」。百度指發布會後一小時內,排隊申請文心一言企業版API調用服務測試的企業用戶已達3萬多間。
百度創始人、董事長兼首席執行官李彥宏表示,「文心一言」現階段仍不完美,但希望搶佔先機,並稱市場對這類產品有巨大需求,短短個多月已有650家企業加入「文心一言」生態圈。
百度昨日股價於發布會後一度挫逾10%,低見120.1元,收市收跌6.36%,報125.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.